Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BRAND ARCHITEKTS GROUP PLC Director's Dealing 2018

Jun 20, 2018

7529_dirs_2018-06-20_6d3e4212-194c-4fb8-ac7d-1e8e5673f752.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9230R

Swallowfield PLC

20 June 2018

Swallowfield plc

("Swallowfield" or "the Company")

Director/PDMR Shareholding

Swallowfield plc, a market leader in the development, formulation, and supply of personal care and beauty products, including its own portfolio of brands announces that it has received notification that on 19 June 2018 Tim Perman, CEO Designate, purchased 12,000 ordinary shares of 5p each in the Company at a price of 324 pence per share and Matthew Gazzard, Group Finance Director, purchased 3,000 ordinary shares of 5p each in the Company at a price of 324 pence per share.

Following the purchases Tim Perman retains a beneficial interest in 12,000 ordinary shares representing 0.07% of the current issued share capital of the Company and Matthew Gazzard retains a beneficial interest in 3,000 ordinary shares representing 0.02% of the current issued share capital of the Company.

For further information, please contact:
Swallowfield plc
Chris How Chief Executive Officer 01823 662 241
Matthew Gazzard Group Finance Director 01823 662 241
Mark Taylor/ Jen Boorer N+1 Singer 0207 496 3000
Josh Royston / Hilary Buchanan Alma PR 07780 901979

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tim Perman

2

Reason for the notification

a)

Position/status

CEO Designate

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Swallowfield plc

b)

LEI

213800BSD8D9QEUKCE17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each

GB0008667304

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
324 pence 12,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

19th June 2018

f)

Place of the transaction

London Stock Exchange

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Gazzard

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Swallowfield plc

b)

LEI

213800BSD8D9QEUKCE17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each

GB0008667304

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
324 pence 3,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

19th June 2018

f)

Place of the transaction

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHFKCDQFBKDFAD